Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 23086769)

1.

Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden.

Young A, Palanisamy N, Siddiqui J, Wood DP, Wei JT, Chinnaiyan AM, Kunju LP, Tomlins SA.

Am J Clin Pathol. 2012 Nov;138(5):685-96. doi: 10.1309/AJCPU7PPWUPYG8OH.

2.

Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.

Salagierski M, Schalken JA.

J Urol. 2012 Mar;187(3):795-801. doi: 10.1016/j.juro.2011.10.133. Epub 2012 Jan 15. Review.

PMID:
22245323
3.

The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.

Xu B, Chevarie-Davis M, Chevalier S, Scarlata E, Zeizafoun N, Dragomir A, Tanguay S, Kassouf W, Aprikian A, Brimo F.

Hum Pathol. 2014 Mar;45(3):488-97. doi: 10.1016/j.humpath.2013.10.012. Epub 2013 Oct 23. Review.

PMID:
24406017
4.

[The progress of TMPRSS2-ETS gene fusions and their mechanism in prostate cancer].

Guo XQ, Gui YT, Cai ZM.

Yi Chuan. 2011 Feb;33(2):117-22. Review. Chinese.

PMID:
21377967
5.

Toward the detection of prostate cancer in urine: a critical analysis.

Truong M, Yang B, Jarrard DF.

J Urol. 2013 Feb;189(2):422-9. doi: 10.1016/j.juro.2012.04.143. Epub 2012 Sep 24. Review.

6.

Prostate-specific antigen and other serum and urine markers in prostate cancer.

Stephan C, Ralla B, Jung K.

Biochim Biophys Acta. 2014 Aug;1846(1):99-112. doi: 10.1016/j.bbcan.2014.04.001. Epub 2014 Apr 13. Review.

PMID:
24727384
7.

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

Auprich M, Bjartell A, Chun FK, de la Taille A, Freedland SJ, Haese A, Schalken J, Stenzl A, Tombal B, van der Poel H.

Eur Urol. 2011 Nov;60(5):1045-54. doi: 10.1016/j.eururo.2011.08.003. Epub 2011 Aug 25. Review.

PMID:
21871709
8.

Urine markers in monitoring for prostate cancer.

Jamaspishvili T, Kral M, Khomeriki I, Student V, Kolar Z, Bouchal J.

Prostate Cancer Prostatic Dis. 2010 Mar;13(1):12-9. doi: 10.1038/pcan.2009.31. Epub 2009 Aug 4. Review.

PMID:
19652665
9.

ERG protein expression as a biomarker of prostate cancer.

Falzarano SM, Magi-Galluzzi C.

Biomark Med. 2013 Dec;7(6):851-65. doi: 10.2217/bmm.13.105. Review.

PMID:
24266818
10.

[Markers for non-invasive molecular genetic diagnosis of oncourological diseases].

Mikhań≠lenko DS, Perepechin DV, Apolikhin OI, Efremov GD, Sivkov AV.

Urologiia. 2014 Sep-Oct;(5):116-20. Review. Russian.

PMID:
25807773
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk